comparemela.com

Latest Breaking News On - Global cancer facts - Page 1 : comparemela.com

Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix

Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Study of ovarian cancer CTCs using Parsortix | Company Announcement

ANGLE INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG TR

The study investigated 123 metastatic ovarian cancer patients over two and a half years using the Parsortix system to assess 474 longitudinal patient samples Downstream qPCR molecular analysis of the Parsortix harvest for ESR1 and ERCC1 genes may be an early predictor of progression free survival and cancer pro.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.